CEACAM5 and colorectal carcinoma: In CRC, serial CEA serum measurements is recommended in postoperative surveillance of stage II and III patients who may be candidates for surgical resection or systemic therapy in the event of distant metastasis and for monitoring of therapy in advanced disease.36